These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors. Yumuk VD. Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746 [Abstract] [Full Text] [Related]
7. Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptor. Galandrin S, Oligny-Longpré G, Bonin H, Ogawa K, Galés C, Bouvier M. Mol Pharmacol; 2008 Jul; 74(1):162-72. PubMed ID: 18403719 [Abstract] [Full Text] [Related]
8. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism. Giaginis C, Tsantili-Kakoulidou A, Theocharis S. Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292 [Abstract] [Full Text] [Related]
11. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells. Sertznig P, Dunlop T, Seifert M, Tilgen W, Reichrath J. Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161 [Abstract] [Full Text] [Related]
12. Peroxisome proliferator-activated receptors and inflammation: take it to heart. Smeets PJ, Planavila A, van der Vusse GJ, van Bilsen M. Acta Physiol (Oxf); 2007 Nov; 191(3):171-88. PubMed ID: 17935522 [Abstract] [Full Text] [Related]
13. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Brown JD, Plutzky J. Circulation; 2007 Jan 30; 115(4):518-33. PubMed ID: 17261671 [Abstract] [Full Text] [Related]
18. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes. Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA. Arterioscler Thromb Vasc Biol; 2006 Jan 21; 26(1):28-40. PubMed ID: 16239592 [Abstract] [Full Text] [Related]
19. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer. Sertznig P, Seifert M, Tilgen W, Reichrath J. J Cell Physiol; 2007 Jul 21; 212(1):1-12. PubMed ID: 17443682 [Abstract] [Full Text] [Related]
20. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Peraza MA, Burdick AD, Marin HE, Gonzalez FJ, Peters JM. Toxicol Sci; 2006 Apr 21; 90(2):269-95. PubMed ID: 16322072 [Abstract] [Full Text] [Related] Page: [Next] [New Search]